A Novel Drosophila-based Drug Repurposing Platform Identified Fingolimod As a Potential Therapeutic for TDP-43 Proteinopathy
Luca Lo Piccolo(Chiang Mai University), Salinee Jantrapirom(Chiang Mai University)
Cited by 9
Related Papers
Dystrophin is required for normal synaptic gain in the Drosophila olfactory circuit
|Brain Research|2019|1